Correction to:Cellular&Molecular Immunology https://doi.org/10.1038/s41423-022-00927-5,published online 30 September 2022 In this article the affliation 2 Smart Immune,Paris,France for P.Gaudeaux was missing.The o...Correction to:Cellular&Molecular Immunology https://doi.org/10.1038/s41423-022-00927-5,published online 30 September 2022 In this article the affliation 2 Smart Immune,Paris,France for P.Gaudeaux was missing.The original article has been corrected.展开更多
Commentary of Moirangthem,R.D.,Ma,K.,Lizot,S.et al.A DL-4-and TNFα-based culture system to generate high numbers of non-modified or genetically modified immunotherapeutic human T-lymphoid progenitors.Cell Mol Immunol...Commentary of Moirangthem,R.D.,Ma,K.,Lizot,S.et al.A DL-4-and TNFα-based culture system to generate high numbers of non-modified or genetically modified immunotherapeutic human T-lymphoid progenitors.Cell Mol Immunol 18,1662–1676(2021).展开更多
文摘Correction to:Cellular&Molecular Immunology https://doi.org/10.1038/s41423-022-00927-5,published online 30 September 2022 In this article the affliation 2 Smart Immune,Paris,France for P.Gaudeaux was missing.The original article has been corrected.
基金supported by the French Institut National de la Santéet de la Recherche Médicale (INSERM),the European Union Seventh Framework Program under grant agreements No.269037 and No.261387the European Union’s Horizon 2020 Research and Innovation Program under grant agreements No.666908 and No.811171+2 种基金state funding from the Agence Nationale de la Recherche under the“Investissement d’avenir”program (ANR-10-IAHU01)the ParisÎle-de-France Region under the“DIM Thérapie génique”initiativethe French Ministry of Health under the 2015 Hospital Clinical Research Program.
文摘Commentary of Moirangthem,R.D.,Ma,K.,Lizot,S.et al.A DL-4-and TNFα-based culture system to generate high numbers of non-modified or genetically modified immunotherapeutic human T-lymphoid progenitors.Cell Mol Immunol 18,1662–1676(2021).
